CsDCS on Functional Mobility in Parkinsons Disease

Recruiting N/A Interventional Study
Parkinson Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
66 (estimated)
Sponsor
Universidade Federal de Pernambuco · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Parkinsons disease is a progressive neurological disorder marked by a decline in the efficacy of dopaminergic synapses in the nigrostriatal pathway, causing motor disturbances. Resting tremor, bradykinesia, and muscle rigidity are the most prominent motor features. These factors result in gait impairments, including slowness and freezing. The primary treatment for the disease is medication. Howeve…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * a clinical diagnosis of PD provided by a neurologist * regular dopaminergic drug treatment (at least three months of use) * aged 40 years or over * staging I to IV on the modified Hoehn and Yahr scale Exclusion Criteria: * other neurological disorders, postural hypotension, …
Contacts

Kátia Monte-Silva

5581986450112

monte.silvakk@gmail.com

CONTACT

João Fabrício

5581986450112

joaovmelo2015@gmail.com

CONTACT